Results 141 to 150 of about 109,551 (247)

Equine botulism

open access: yesEquine Veterinary Journal, Volume 58, Issue 2, Page 333-347, March 2026.
Abstract Botulism is a severe and often fatal disease in equine patients worldwide. Clostridium botulinum is a ubiquitous soil organism which produces a potent neurotoxin resulting in neuromuscular blockade and flaccid paralysis in affected animals. Definitive diagnosis is often impractical or impossible, leading to diagnosis and treatment based on ...
Kali Slavik   +2 more
wiley   +1 more source

Plasma C‐reactive protein and interleukin‐6 concentrations in foals during health and respiratory disease

open access: yesEquine Veterinary Journal, Volume 58, Issue 2, Page 372-379, March 2026.
Abstract Background Early and specific diagnosis of bronchopneumonia in foals is important to prevent severe disease. In human medicine, C‐reactive protein (CRP) and interleukin‐6 (IL‐6) are important diagnostic and prognostic biomarkers in neonatal pneumonia in other species.
Dorothea Hildebrandt   +3 more
wiley   +1 more source

Clinical signs, clinical pathology and outcomes in horses infected naturally with equine encephalosis virus

open access: yesEquine Veterinary Journal, Volume 58, Issue 2, Page 434-443, March 2026.
Abstract Background Equine encephalosis (EE) is caused by an Orbivirus from the family Sedoreoviridae and is thus similar to African horse sickness (AHS) and Bluetongue viruses (BTV). These viruses are transmitted by Culicoides midges. Equine encephalosis can infect horses, donkeys and zebras sub‐clinically while only horses develop clinical disease ...
Graeme Piketh   +2 more
wiley   +1 more source

Phase 1 Dose Escalation of Single‐Agent Mechlorethamine in Dogs With Lymphoma

open access: yesVeterinary and Comparative Oncology, Volume 24, Issue 1, Page 51-57, March 2026.
ABSTRACT Mechlorethamine is commonly prescribed to dogs at 3 mg/m2. The minimal toxicity observed indicates that higher doses of mechlorethamine are likely tolerable. The primary objective of this study was to determine the maximally tolerated dose (MTD) of mechlorethamine in dogs with lymphoma.
Laura E. Chadsey   +2 more
wiley   +1 more source

An update on alternatives to antimicrobial growth promoters for broilers [PDF]

open access: yes, 2011
Ducatelle, Richard   +2 more
core   +1 more source

Isolated immune-mediated enteritis in patients treated with immune checkpoint inhibitor therapy. [PDF]

open access: yesAnn Gastroenterol
Wali S   +13 more
europepmc   +1 more source

Enteric fever

open access: yesBMJ, 2021
Basnyat, Buddha   +4 more
openaire   +3 more sources

Outcome and Toxicity Profile of Stereotactic Body Radiation Therapy for Adrenal Tumours in Dogs

open access: yesVeterinary and Comparative Oncology, Volume 24, Issue 1, Page 150-159, March 2026.
ABSTRACT Stereotactic body radiation therapy (SBRT) has become a non‐invasive alternative option for canine adrenal tumours with high surgical risks; however, its clinical benefits and risks are still to be fully understood. The goal of this multi‐institutional retrospective study was to describe the clinical outcome and safety of SBRT for the ...
Lily Thorsen   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy